Dr. Nazemzadeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4525 Cameron Valley Pkwy
Suite 3500
Charlotte, NC 28211Phone+1 704-302-8300Fax+1 704-302-8301- Is this information wrong?
Education & Training
- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2000 - 2003
- McGovern Medical School at UTHealthClass of 2000
Certifications & Licensure
- NC State Medical License 2006 - 2024
- TN State Medical License 2003 - 2006
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2011-2014
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2011-2014
Clinical Trials
- S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride Start of enrollment: 2011 Nov 15
- A Study of Regorafenib in Advanced Pancreatic Cancer Patients Start of enrollment: 2014 Jun 06
Publications & Presentations
PubMed
- 6 citationsCobimetinib Plus Vemurafenib in Patients With Colorectal Cancer WithMutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.Kelsey A Klute, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Reza Nazemzadeh, Kathleen J Yost, Herbert L Duvivier, Eugene R Ahn, Timothy L Cannon, Olatunji B ...> ;JCO Precision Oncology. 2022 Nov 1
- A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metast...O'Neil BH, Scott AJ, Ma WW, Cohen SJ, Aisner DL, Menter AR, Tejani MA, Cho JK, Granfortuna J, Coveler AL, Olowokure OO, Baranda JC, Cusnir M, Phillip P, Boles J, Nazem...> ;Ann. Oncol.. 2016-06-01
- A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metast...O'Neil BH, Scott AJ, Ma WW, Cohen SJ, Leichman L, Aisner DL, Menter AR, Tejani MA, Cho JK, Granfortuna J, Coveler L, Olowokure OO, Baranda JC, Cusnir M, Phillip P, Bol...> ;Ann. Oncol.. 2015-12-01
- Join now to see all
Press Mentions
- Gut Health Is Important for All AgesFebruary 24th, 2023
Professional Memberships
- Member
Hospital Affiliations
- Atrium Health's Carolinas Medical CenterCharlotte, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: